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The N-end rule relates the in vivo half-life of a protein to the identity of its N-terminal residue. The
underlying ubiquitin-dependent proteolytic system, called the N-end rule pathway, is organized hierarchically:
N-terminal aspartate and glutamate (and also cysteine in metazoans) are secondary destabilizing residues, in
that they function through their conjugation, by arginyl-tRNA-protein transferase (R-transferase), to arginine,
a primary destabilizing residue. We isolated cDNA encoding the 516-residue mouse R-transferase, ATE1p, and
found two species, termed Ate1-1 and Ate1-2. The Ate1 mRNAs are produced through a most unusual alternative
splicing that retains one or the other of the two homologous 129-bp exons, which are adjacent in the mouse Ate1
gene. Human ATE1 also contains the alternative 129-bp exons, whereas the plant (Arabidopsis thaliana) and fly
(Drosophila melanogaster) Ate1 genes encode a single form of ATE1p. A fusion of ATE1-1p with green fluorescent
protein (GFP) is present in both the nucleus and the cytosol, whereas ATE1-2p–GFP is exclusively cytosolic.
Mouse ATE1-1p and ATE1-2p were examined by expressing them in ate1D Saccharomyces cerevisiae in the
presence of test substrates that included Asp-bgal (b-galactosidase) and Cys-bgal. Both forms of the mouse
R-transferase conferred instability on Asp-bgal (but not on Cys-bgal) through the arginylation of its N-
terminal Asp, the ATE1-1p enzyme being more active than ATE1-2p. The ratio of Ate1-1 to Ate1-2 mRNA varies
greatly among the mouse tissues; it is ;0.1 in the skeletal muscle, ;0.25 in the spleen, ;3.3 in the liver and
brain, and ;10 in the testis, suggesting that the two R-transferases are functionally distinct.
The half-lives of intracellular proteins range from a few
seconds to many days. The rates of processive proteolysis are a
function of the cell’s physiological state and are controlled
differentially for specific proteins. In particular, most of the
damaged or otherwise abnormal proteins are metabolically
unstable. Many other proteins, while long-lived as components
of larger macromolecular structures such as ribosomes and
oligomeric proteins, are metabolically unstable as free sub-
units. Regulatory proteins are often also short-lived in vivo,
providing a way to generate their spatial gradients and to
rapidly adjust their concentrations, or subunit compositions,
through changes in the rate of their synthesis or degradation
(20, 23, 28, 39, 44, 55).
The posttranslational conjugation of arginine (Arg) to the N
termini of eukaryotic proteins was described 35 years ago (26),
but the function of this modification, and of the enzyme in-
volved, Arg-tRNA-protein transferase (R-transferase) (47), re-
mained unknown until the discovery that the identity of N-
terminal residue in a protein influences its metabolic stability
(4). The resulting relation was termed the N-end rule (54).
Aspartate (Asp) and glutamate (Glu), the two N-terminal res-
idues known to be arginylated by R-transferase (47), were
shown to be destabilizing residues in the N-end rule (4). It was
therefore proposed (4) that the function of R-transferase is to
target proteins for degradation by conjugating Arg, one of the
primary destabilizing residues, to secondary destabilizing N-
terminal residues (Asp and Glu in fungi; Asp, Glu, and Cys in
metazoans (18) (Fig. 1). It was also proposed (4) that the
analogous prokaryotic enzyme Leu, Phe-tRNA-protein trans-
ferase (L, F-transferase) (47) mediates the activity of N-termi-
nal Arg and Lys, which, in prokaryotes, would be the secondary
destabilizing residues. These conjectures were confirmed (7,
17, 45, 53).
The similar but distinct degradation signals which together
give rise to the N-end rule are called the N-degrons (54, 56). In
eukaryotes, an N-degron comprises two determinants: a desta-
bilizing N-terminal residue and an internal Lys residue of a
substrate (5, 22). The Lys residue is the site of formation of a
substrate-linked multiubiquitin chain (11). The N-end rule
pathway is thus one pathway of the ubiquitin (Ub) system. Ub
is a 76-residue protein whose covalent conjugation to other
proteins plays a role in a multitude of processes, including cell
growth, division, differentiation, and responses to stress (20,
23, 39, 55). In many of these processes, Ub acts through routes
that involve the degradation of Ub-protein conjugates by the
26S proteasome, an ATP-dependent multisubunit protease (9,
13, 40, 43).
(In the text that follows, names of mouse genes are in italics,
with the first letter uppercase. Names of human and Saccha-
romyces cerevisiae genes are also in italics, all uppercase. If
human and mouse genes are named in the same sentence, the
mouse gene notation is used. Names of S. cerevisiae proteins
are roman, with the first letter uppercase and an extra lower-
case “p” at the end. Names of the corresponding mouse and
human proteins are the same, except that all letters but the last
“p” are uppercase. The latter usage is a modification of the
existing convention (50), to facilitate simultaneous discussions
of yeast, mouse, and human proteins. In some citations, the
abbreviated name of a species precedes the gene’s name.)
The N-end rule is organized hierarchically. In the yeast S.
cerevisiae, Asn and Gln are tertiary destabilizing N-terminal
residues in that they function through their conversion, by the
NTA1-encoded N-terminal amidase (Nt-amidase) (6), to the
secondary destabilizing N-terminal residues Asp and Glu. The
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destabilizing activity of N-terminal Asp and Glu requires their
conjugation, by the S. cerevisiae ATE1-encoded Arg-tRNA-
protein transferase (R-transferase), to Arg, one of the primary
destabilizing residues (7) (Fig. 1B). In mammals, the deami-
dation step is bifurcated, in that two distinct Nt-amidases spe-
cific, respectively, for N-terminal Asn and Gln, mediate the
activity of tertiary destabilizing residues (19, 51) (Fig. 1A).
Mice lacking the Asn-specific Nt-amidase NTAN1p have re-
cently been produced through targeted mutagenesis and found
to be fertile, outwardly normal, but behaviorally distinct from
their congenic wild-type counterparts (28a). In mammals, the
set of secondary destabilizing residues contains not only Asp
and Glu but also Cys, which is a stabilizing residue in yeast (18,
54) (Fig. 1).
The primary destabilizing N-terminal residues are bound
directly by the UBR1-encoded N-recognin (also called E3a),
the recognition component of the N-end rule pathway (8). In S.
cerevisiae, N-recognin is a 225-kDa protein that binds to po-
tential N-end rule substrates through their primary destabiliz-
ing N-terminal residues, Phe, Leu, Trp, Tyr, Ile, Arg, Lys, and
His (54). The Ubr1 genes encoding mouse and human N-
recognins, also called Ea (21, 41), have been cloned (29), and
mouse strains lacking Ubr1 have recently been constructed
(29a).
The known functions of the N-end rule pathway include the
control of peptide import in S. cerevisiae, through the degra-
dation of Cup9p, a transcriptional repressor of PTR2 which
encodes the peptide transporter (2, 10); a role in regulating the
Sln1p-dependent phosphorylation cascade that mediates os-
moregulation in S. cerevisiae (38); the degradation of Gpa1p, a
Ga protein of S. cerevisiae (34); and the conditional degrada-
tion of alphaviral RNA polymerase in virus-infected metazoan
cells (16, 54). Physiological N-end rule substrates were also
identified among the proteins secreted into the host cell’s cy-
tosol by intracellular parasites such as the bacterium Listeria
monocytogenes (46). Inhibition of the N-end rule pathway was
reported to interfere with mammalian cell differentiation (24)
and to delay limb regeneration in amphibians (52). Microar-
ray-based comparisons of gene expression patterns in wild-type
and congenic ubr1D strains of S. cerevisiae have shown that a
number of yeast genes, of diverse functions, are significantly
up- or down-regulated in the absence of the N-end rule path-
way (39a).
The mammalian counterpart of the yeast ATE1-encoded
R-transferase was partially purified from rabbit reticulocytes
and shown to cofractionate with Arg-tRNA synthetase (12).
Recent studies of the Ub-dependent proteolysis of endogenous
proteins in muscle extracts suggested that the N-end rule path-
way plays a major role in catabolic states that result in muscle
atrophy (48, 49). A significant fraction of the N-end rule path-
way’s activity in muscle extracts was found to be tRNA depen-
dent, indicating the involvement of R-transferase (48, 49). It
was also reported that a crush injury to the rat sciatic nerve
results in a ;10-fold increase in the rate of arginine conjuga-
tion to the N termini of unidentified proteins in the nerve’s
region upstream of the crush site (15, 57), suggesting an injury-
induced increase in the concentration of R-transferase sub-
strates and/or an enhanced activity of the N-end rule pathway.
In this work, we began the functional analysis of mammalian
R-transferase (ATE1p) by isolating mouse cDNA encoding
this enzyme. Surprisingly, we found two Ate1 cDNA species,
which were identical except for a 129-bp region that encoded
similar but distinct sequences. One or the other, but not both,
of the corresponding Ate1 exons is retained in the mature Ate1
mRNA, and the ratio of the resulting two species, Ate1-1 and
Ate1-2, varies greatly among mouse tissues. We also show that
ATE1-1p and ATE1-2p, while differing in activity, can argin-
ylate N-terminal Asp and Glu in model substrates. However,
neither of them can arginylate N-terminal Cys, the known
secondary destabilizing residue (18), suggesting the existence
of a distinct Cys-specific mammalian R-transferase.
MATERIALS AND METHODS
Strains and plasmids. The S. cerevisiae strains used were JD55 (MATa ura3-52
his3-D200 leu2-3,112 trp1-D63 lys2-801 ubr1D::HIS3) (34) and SGY3 (MATa
ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-D1ate1-D2::LEU2) (19a). Cells
were grown in rich medium (YPD) or in synthetic media (SD) containing 0.67%
yeast nitrogen base without amino acids (Difco), auxotrophic nutrients, and 2%
glucose. To induce the PGAL promoter, glucose was replaced by 2% galactose
(SG medium). Transformation of S. cerevisiae was performed by the lithium
acetate method (3).
The ubr1D ate1D double mutant AVY34 was constructed by replacing 93% of
the ATE1 open reading frame (ORF) (the first 470 codons) in strain JD55
(ubr1D) by the LEU2 gene, through homologous recombination (42) with the
introduced LEU2 gene flanked on either side by 40 bp of ATE1-specific se-
quences. Mutants were selected on SD (lacking Leu and His) plates, and Leu1
isolates were checked by PCR for the absence of ATE1 and by colony assays (7,
8) for the absence of Ate1p and Ubr1p activity. High-copy-number pUB23-X
plasmids expressing Ub-X-bgal proteins (see below) from PGAL in S. cerevisiae
have been described elsewhere (4). Mouse Ate1-1 and Ate1-2 cDNAs (see below)
were subcloned into the low-copy-number vector p414GAL1 (36), using the
engineered BamHI (59) and XhoI (39) restriction sites, yielding plasmids pAT1
and pAT2. For localization assays with green fluorescent protein (GFP), cDNAs
encoding mouse ATE1-1p or ATE1-2p were subcloned into the pEGFP-N1
N-terminal protein fusion vector (Clontech, Palo Alto, Calif.), using the engi-
neered XhoI (59) and AgeI (39) restriction sites, yielding plasmids pAT1-GFP and
pAT2-GFP.
Isolation of the mouse Ate1-1 and Ate1-2 cDNAs. The 392-bp fragment of the
mouse EST (expressed sequence tag) clone (accession no. AA415294), which was
identified in GenBank through species walking (see Results), was used as a probe
to screen a lgt10-based mouse cDNA library from MEL-C19 cells (Clontech),
using standard procedures (3). Eight positive clones, whose inserts ranged from
0.5 to 1.6 kb, were analyzed by PCR and partial sequencing. The cDNA inserts
of clones 3 and 8 were then subcloned into pBluescript II SK1 (29) and se-
quenced on both strands. The resulting ORFs were identical except for a 129-bp
internal region (see Results) (Fig. 2A). The deduced amino acid sequences of the
mouse cDNA clones 3 and 8 were weakly but significantly similar to the deduced
sequences of Caenorhabditis elegans and S. cerevisiae ATE1p (see Results) (Fig.
2B) and corresponded to nucleotides (nt) 699 to 1870 and 587 to 2099, respec-
tively, in the subsequently produced full-length mouse Ate1-1 and Ate1-2 cDNAs
(accession no. AF079096 and AF079097).
A human EST clone (accession no. AA503372) whose deduced amino acid
sequence was highly similar to that of the partial mouse Ate1 cDNA clone 8 was
found in GenBank, using the partial mouse ATE1p sequence as a query. This
EST clone was purchased from Genome Systems (St. Louis, Mo.) and sequenced
FIG. 1. Comparison of enzymatic reactions that underlie the activity of the
tertiary and secondary destabilizing residues among eukaryotes. (A) Mammals
(reference 54 and this work); (B) the yeast S. cerevisiae (5). N-terminal residues
are indicated by single-letter abbreviations for amino acids; ovals denote the rest
of a protein substrate. The Ntan1-encoded mammalian Nt-amidase converts
N-terminal Asn to Asp, whereas N-terminal Gln is deamidated by a distinct
Nt-amidase that remains to be identified (19, 51). In contrast, the yeast Nt-
amidase can deamidate either N-terminal Asn or Gln (6). The secondary desta-
bilizing residues Asp and Glu are arginylated by the mammalian ATE1-1p or
ATE1-2p R-transferase (see Results). A Cys-specific mammalian R-transferase
remains to be identified (see Results). N-terminal Arg, one of the primary
destabilizing residues (54), is recognized by N-recognin (E3) (see the introduc-
tion).
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to obtain more of the 59-proximal human ATE1 sequence. Reverse transcription-
PCR (RT-PCR) (3) was then carried out with poly(A)1 RNA from mouse
embryonic fibroblasts, using the mouse Ate1-specific reverse primer 59-CCTTT
GGTAACAAACAGACTGGCTG-39 and the forward primer 59-TCTCATAG
ACCGAGGATGGCGAAG-39, whose sequence was derived from the above
human EST clone. The resulting PCR products, which appeared as a smear upon
agarose gel electrophoresis, were ligated into the TA cloning vector (Invitrogen,
San Diego, Calif.), and the ligation mixture was used as a template for PCR using
a nested mouse Ate1 primer 59-CTGCAGCTGAGGCCTGCTGCATCCG-39
and a vector-specific primer 59-GTTTTCCCAGTCACGAC-39. This strategy
yielded a single major DNA species (data not shown). We then applied 59-RACE
(rapid amplification of 59 cDNA ends) (3), using the above RT-PCR-derived
sequence, to produce the full-length Ate1 cDNA as previously described (19).
Analysis of the mouse Ate1 gene. The mouse genomic DNA from L cells was
used as a template for PCR, using the Expand high-fidelity PCR system (Boehr-
inger, Indianapolis, Ind.) and exon-specific primers as previously described (29),
to produce DNA fragments that together spanned ;4 kb of the mouse Ate1 gene
and contained the two alternative 129-bp Ate1 exons. The regions encompassing
exon/intron junctions were sequenced by using exon- and intron-specific primers.
Thereafter, a strategy described earlier for the Ubr1 gene (29) was used to screen,
using a fragment of the mouse Ate1 cDNA (nt 255-1139), a BAC (bacterial
artificial chromosome)-based library of mouse genomic DNA fragments from
strain 129SvJ (Genome Systems), yielding one BAC clone containing the mouse
Ate1 gene.
Isolation of the human, plant, and fly ATE1 cDNAs. Using the cloned mouse
ATE1p sequences (see above) as queries, we identified in GenBank several
significantly similar EST sequences from other organisms (data not shown). To
determine whether these species also contained the two forms of ATE1 mRNA,
we isolated the corresponding ATE1 cDNAs. RT-PCR (3) with poly(A)1 RNA
from human 293 cells and the primers 59-CAATGGCATGTGGGCACATTCC
ATG-39 (specific for the human EST clone AA503372 [see above]) and 59-CC
ACAGGTACTGAATATGTATCCTG-39 (specific for the human EST clone
AA195361) was carried out, yielding a 1.6-kb human ATE1 cDNA fragment
lacking the first 41 codons of the ATE1 ORF. This fragment (a mixture of the two
alternative cDNAs) was subcloned into the TA vector (Invitrogen) and se-
quenced on both strands. Full-length Ate1 cDNAs from Arabidopsis thaliana and
Drosophila melanogaster were isolated by RT-PCR as well, using total RNA from
A. thaliana leaves, poly(A)1 RNA from D. melanogaster embryos, and primers
specific for the 59 and 39 ends of the corresponding ORFs. By using the strategy
described above for the human ATE1 cDNAs, the sequences of these primers
were derived from the EST clones that were initially identified in GenBank through
their similarity to the mouse ATE1p sequence, then purchased from Genome Sys-
tems, and sequenced prior to RT-PCR with the corresponding RNA preparations.
The final human, plant, and fly ATE1 cDNAs were sequenced on both strands.
Assays of b-gal. Colony assays for the Escherichia coli b-galactosidase (bgal)
in S. cerevisiae were carried out by overlaying yeast colonies on SG plates with
0.5% agarose containing 0.1% sodium dodecyl sulfate (SDS), 4% dimethylfor-
mamide, and a 0.1-mg/ml solution of the chromogenic bgal substrate X-Gal
(5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside; Calbiochem, La Jolla, Cal-
if.), followed by incubation for 1 to 2 h at 37°C. Quantitative assays for bgal in
S. cerevisiae were carried out with whole-cell extracts, using another chromogenic
bgal substrate, o-nitrophenyl-b-D-galactopyranoside (ONPG). Cells in a 5-ml
culture (A600 of ;1) were pelleted by centrifugation and resuspended in 5 ml of
buffer Z (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 50
mM b-mercaptoethanol [pH 7.0]). After the A600 of the suspension was deter-
mined 50- or 100-ml samples were diluted to 1 ml with buffer Z; 0.1% SDS (20
ml) and CHCl3 (50 ml) were then added; the suspension was vortexed for 10 to
15 s and incubated for 15 min at 30°C, followed by the addition of 200 ml of
ONPG (4 mg/ml in buffer Z) and further incubation at 30°C, until a medium
yellow color had developed, at which point the reaction was stopped by the
addition of 1 M Na2CO3 (0.4 ml). The mixture was centrifuged for 5 min at
1,100 3 g, and the A420 and A500 of the samples were measured. The ONPG units
(UONPG) of bgal activity were calculated as follows: UONPG 5 1,000 3 [(A420) 2
(1.75 3 A500)]/t 3 v 3 A600, where t and v were, respectively, the time of
incubation (minutes) and the sample volume (milliliters) (3).
Purification and N-terminal sequencing of X-bgal proteins. Extracts were
prepared (using the liquid nitrogen procedure [3]) from S. cerevisiae AVY34
(ubr1D ate1D) cotransformed with a pUB23-X plasmid (4) (expressing Ub-X-
bgal) and either pAT1 (expressing mouse ATE1-1p) or pAT2 (expressing mouse
ATE1-2p). Cultures were grown in SG to an A600 of ;1. Specific X-bgal proteins
(X 5 Asp or Cys) were purified by affinity chromatography on ProtoSorb lacZ
(Promega, Madison, Wis.), a monoclonal anti-bgal antibody coupled to agarose
beads (Promega). X-bgal proteins were further purified by electrophoresis on
SDS–7% polyacrylamide gels and were electroblotted onto Immobilon-PSQ
membranes (Millipore, Bedford, Mass.). N-terminal sequencing of 10 to 15 pmol
of electroblotted X-bgal was carried out for at least five cycles, using an Applied
Biosystems 476A protein sequencer (Caltech Microchemistry Facility).
Mouse cell cultures, transfection, and GFP localization. NIH 3T3 cells (ATCC
1658-CRL) were grown as monolayers in Dulbecco’s modified Eagle medium
(GIBCO, Frederick, Md.) supplemented with 10% fetal bovine serum. Cells for
GFP localization analyses were grown to ;15% confluence on glass coverslips
for 24 h prior to transfection with either pAT1-GFP or pAT2-GFP, using Lipo-
fectamine (GIBCO) and the manufacturer-supplied protocol. Cells were incu-
bated for 5 h at 37°C in serum-free medium containing DNA and Lipofectamine.
Thereafter an equal volume of medium containing 20% serum was added, and
the cells were grown for another 12 to 20 h at 37°C. Cells were fixed with 2%
formaldehyde in phosphate-buffered saline, and GFP fluorescence was visualized
in a Zeiss Axiophot microscope.
Northern hybridization. Mouse multiple-tissue Northern blots containing 2 mg
of poly(A)1 RNA per lane (Clontech) were probed with the 32P-labeled 1.1-kb
mouse Ate1 cDNA (nt 638 to 1734), using the manufacturer-supplied protocol.
Determination of the relative levels of Ate1-1 and Ate1-2 mRNAs. Samples of
total RNA isolated as described previously (3) from mouse spleen, skeletal
muscle, liver, brain, testis, and embryonic fibroblasts were subjected to RT-PCR
(28 cycles). The primers 59-CAGTGGAGGATGCTGTTGACGGTGAC-39 and
59-GTGCTCTGCCTCCAATGGTGAGCTG-39 were specific for the identical
regions of Ate1-1 and Ate1-2 cDNAs that flanked the two 129-bp exons (see
Results) which distinguished these cDNAs. The resulting 624-bp product (a
mixture of the Ate1-1 and Ate1-2 cDNA fragments) was treated with ScrFI, which
cuts at different sites within the two 129-bp exons, followed by a 2% agarose gel
electrophoresis. This procedure made it possible to distinguish the Ate1-1 and
Ate1-2 fragments. The ratios of the two forms of Ate1 cDNA were determined by
serial dilutions of the samples prior to gel electrophoresis.
Nucleotide sequence accession numbers. The nucleotide sequences reported
in this paper were submitted to the GenBank/EMBL data bank and assigned
accession no. AF079096 (mouse Ate1-1 cDNA), AF079097 (mouse Ate1-2 cDNA),
AF079098 (human Ate1-1 cDNA), AF079099 (human ATE1-2 cDNA), AF079100
(A. thaliana Ate1 cDNA), and AF079101 (D. melanogaster Ate1 cDNA).
RESULTS
Identification of mouse Ate1 cDNAs by species walking. On
the assumption that the sequences of R-transferases in differ-
ent species might be sufficiently conserved to be detected by
using the sequence of the only cloned R-transferase, S. cerevi-
siae Ate1p (7), we have been searching GenBank and related
databases. No mammalian sequences in GenBank, including
the EST sequences, had significant similarities to S. cerevisiae
Ate1p. However, we did identify a nematode (C. elegans) ORF
(accession no. Z21146) that exhibited similarity to yeast Ate1p
(Fig. 2B) and then used the C. elegans sequence to identify a
FIG. 2. Two forms of the mouse Ate1 cDNA and the ATE protein family. (A) The mouse Ate1-1 and Ate1-2 cDNAs and their products. The nucleotide sequences
of Ate1-2 identical to those of Ate1-1 (everywhere except for the 129-bp region) are indicated by dashes. In the region of the alternative 129-bp exons of Ate1-1 and
Ate1-2, white-on-black and gray shadings highlight, respectively, identical and similar residues. The circled Cys residues are homologous to those that are important
for the enzymatic activity of S. cerevisiae Ate1p (32). (B) The ATE protein family and the origins of the alternative 129-bp exons. Alignment of the sequences of mouse
ATE1-1p (Mm-Ate1-1), A. thaliana Ate1p (At-Ate1), D. melanogaster Ate1p (Dm-Ate1), C. elegans Ate1p (Ce-Ate1), and S. cerevisiae Ate1p (Sc-Ate1) (accession no.
J05404). Similar residues (gray) were grouped as follows: M, L, I, and V; D, E, N, and Q; R, K, and H; Y, F, and W; S, A, and T. The region encoded by the alternative
129-bp exons of mouse Ate1 is highlighted by a thick line. Of the Cys residues that are conserved among all ATE proteins, the ones required and not required for the
enzymatic activity of S. cerevisiae Ate1p (32) are indicated, respectively, by  and . The N-terminally truncated mouse ATE1-1p and ATE1-2p proteins which began
at Met-42 (F) lacked the R-transferase activity (data not shown). The highly variable C-terminal regions of ATE proteins were omitted from the alignment. The
sequences were aligned using PileUp program (Wisconsin Package; Genetics Computer Group, Madison, Wis.). Gaps (2) were introduced to optimize the alignment.
The residue numbers are on the right of the sequences. The sequence of C. elegans Ate1p appears to lack the N-terminal region of other ATE proteins because of an
error in defining the Ate1 ORF in the genomic DNA sequence (accession no. Z21146). (C) Alignment of the 43-residue regions that are encoded by the alternative
129-bp exons in mammalian Ate1. Sequences shown: mouse (Mm-Ate1-1 and Mm-Ate1-2), human (Hs-Ate1-1 and Hs-Ate1-2), D. melanogaster (Dm-Ate1), C. elegans
(Ce-Ate1), A. thaliana (At-Ate1), S. pombe (Sp-Ate1; accession no. Z99568), and S. cerevisiae (Sc-Ate1) (accession no. J05404). The degrees of identity and similarity
of ATE proteins to the deduced amino acid sequences of the M8 (mouse ATE1-1p) or M3 (mouse ATE1-2p) exon of the mouse Ate1 gene are indicated on the right.
The residues conserved among all of the compared sequences are indicated above the alignment.
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significantly similar EST sequence of D. melanogaster cDNA
(accession no. AA391570). Finally, using the deduced amino
acid sequence of the Drosophila EST clone as a probe, we
identified a 467-bp mouse EST sequence (accession no.
AA415294) that exhibited weak but significant similarity to the
Drosophila sequence but no detectable similarity to S. cerevi-
siae Ate1p. On a chance that this 467-bp EST had been derived
from the mouse Ate1 cDNA, we used it to screen a mouse
cDNA library and indeed isolated the putative mouse Ate1
cDNAs (Fig. 2A).
Alternative splicing results in two species of mouse Ate1
cDNA containing distinct but homologous exons. During the
initial mouse cDNA library screening, we found that the cDNA
clone 3 (nt 699 to 1870 of Ate1-2 cDNA) was identical to the
cDNA clone 8 (nt 587 to 2099 of Ate1-1 cDNA), except for a
129-bp region whose deduced amino acid sequences were sim-
ilar (31% identity; 61% similarity) (Fig. 2). The two full-length
Ate1 cDNAs (termed Ate1-1 and Ate1-2), which were obtained
by RT-PCR followed by 59-RACE (see Materials and Meth-
ods), encoded proteins of identical length, 516 residues (59.2
kDa and pI of 8.14 versus 59.1 kDa and pI of 7.22) (Fig. 2A),
that contained regions of similarity to the 57.8-kDa Ate1p of S.
cerevisiae (Fig. 2B). RT-PCR (followed by subcloning) with
RNAs from different mouse tissues also produced the two
forms of Ate1 cDNAs, indicating that the two species were in
fact present in the initial RNA preparation (Fig. 3 and data not
shown).
To determine whether both of the two 129-bp regions of the
Ate1-1 and Ate1-2 cDNAs were a part of the Ate1 gene, and
whether Ate1-1 and Ate1-2 were produced through alternative
splicing, we analyzed the mouse Ate1 gene in the vicinity of its
two 129-bp exons, using at first PCR and subsequently a BAC
clone containing Ate1 (see Materials and Methods). The two
129-bp exons were located next to each other in the Ate1 gene
(Fig. 4A). We also found that the 12-bp sequences around the
splice acceptor sites of these exons (6 bp in the intron and 6 bp
in the exon) were identical between the two exons (Fig. 4B),
consistent with the alternative presence of these exons in the
mature Ate1 mRNA. The exon-containing RT-PCR products
from different mouse tissues appeared as a single major band
retaining one of the two 129-bp exons (Fig. 3 and data not
shown). Subcloning and analyses of these RT-PCR products
yielded no other differentially spliced Ate1 cDNAs (for exam-
ple, cDNAs retaining both or neither of the two 129-bp exons),
suggesting that the splicing of Ate1 pre-mRNA is tightly regu-
lated to retain one and only one of the two alternative exons.
Thus, the two forms of Ate1 mRNAs are produced by a nearly
unprecedented (see Discussion) splicing pathway which ulti-
mately yields two proteins of identical size that bear two alter-
native, homologous but distinct 43-residue internal sequences
(Fig. 4C).
The absence of alternative 129-bp exons from the plant and
fly Ate1 genes. To explore the evolution of Ate1, and especially
the phylogeny of its alternative 129-bp exons, we cloned the
human, plant (A. thaliana), and fly (D. melanogaster) ATE1
cDNAs (see Materials and Methods). Two forms of the human
ATE1 cDNA, termed Hs-ATE1-1 and Hs-ATE1-2, were iso-
lated from human 293 cells (the forms’ molar ratio was about
1). However, only one form of the Ate1 cDNA was isolated
from either the leaves of A. thaliana (termed At-Ate1) or D.
melanogaster embryos (termed Dm-Ate1), suggesting that the
alternative 129-bp exons may not be present in the Ate1 genes
of plants and arthropods. The A. thaliana and D. melanogaster
Ate1p proteins were, respectively, 629 and 477 residues long
(71 and 55 kDa, with pIs of 6.0 and 8.4). Mouse ATE1-1p was
82, 38, and 42% identical (as well as 91, 57, and 61% similar)
to human ATE1-1p, A. thaliana Ate1p, and D. melanogaster
Ate1p, respectively (Fig. 2 and data not shown). A. thaliana
Ate1p bore a 16-residue region containing exclusively Asp or
Glu (data not shown).
We used RT-PCR and RNA preparations from A. thaliana
and D. melanogaster to amplify the relevant regions of the
corresponding Ate1 cDNAs. The resulting fragments were di-
gested with restriction enzymes that recognize, in each species,
exclusively the region that corresponds to the 129-bp exons of
the mouse Ate1 cDNAs, and the products were analyzed by gel
electrophoresis. The initial cDNA fragments of A. thaliana and
D. melanogaster Ate1 completely disappeared after this treat-
ment, in contrast to the homologous mouse cDNA fragment
(which contained two distinct sequences of identical length),
suggesting that the two alternative exons were absent from the
Ate1 genes of plants and arthropods (Fig. 5A).
While this analysis was under way, complete sequences of
FIG. 3. Expression of Ate1-1 and Ate1-2 mRNAs in different mouse tissues
and mouse embryonic fibroblasts (MEF). Two forms of Ate1 cDNA (Fig. 2A)
were amplified in a single reaction by RT-PCR, using the same primers, to yield
624-bp fragments that included the region of the alternative 129-bp exons (see
Materials and Methods). The 624-bp fragments were digested with ScrFI, which
produced a 231-bp fragment (a mixture of Ate1-1 and Ate1-2), a 284-bp, Ate1-
1-specific fragment, and a 317-bp, Ate1-2-specific fragment. The untreated (lanes
a) and ScrFI-treated (lanes b) samples from different mouse tissues were ana-
lyzed by electrophoresis in a 2% agarose gel. The ratio of the two forms of Ate1
mRNA, defined as the ratio of the 284-bp (Ate1-1) fragment to the 317-bp
(Ate1-2) fragment, was determined by analyzing serially diluted samples and
comparing the resulting band intensities (data not shown). sk., skeletal.
FIG. 4. The two forms of mouse Ate1 mRNA are produced by alternative
splicing. (A) The two alternative 129-bp exons are adjacent in the mouse Ate1
gene. The thick line denotes genomic DNA; the striped and black rectangles
denote the alternative 129-bp exons, M8 and M3 (see Materials and Methods);
gray rectangles denote the flanking Ate1 exons, of unknown sizes; thin lines
denote the alternative splicing patterns that yield the two forms of Ate1 mRNA.
(B) The underlined 12 bp (6 bp in the intron and 6 bp in the exon) around the
splice acceptor sites are identical between the two alternative 129-bp exons. (C)
Scale diagrams of the two forms of mouse Ate1 cDNAs. The alternative 129-bp
exons M8 and M3 are indicated by the striped and black boxes, respectively.
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the A. thaliana and D. melanogaster Ate1 loci, determined
through the corresponding sequencing projects, were depos-
ited in GenBank (accession no. AA005237 and accession no.
AC004321, respectively). By comparing the cloned Ate1 cDNAs
(see Materials and Methods) and the corresponding genomic
sequences of A. thaliana and D. melanogaster, we could deduce
the organization of these Ate1 genes. The results (Fig. 5B)
directly confirmed the absence of the alternative homologous
exons from Ate1 of A. thaliana and D. melanogaster, in contrast
to mammalian Ate1. The corresponding region of plant Ate1p
is more similar to the exon-encoded sequence of mouse ATE1-
1p, whereas in Drosophila this region is more similar to the
alternative sequence of ATE1-2p (Fig. 2C). The corresponding
regions of S. cerevisiae and Schizosaccharomyces pombe Ate1p
are not preferentially similar to either of the two alternative
exon-encoding sequences of mouse ATE1p (Fig. 2C).
Mouse ATE1-1p and ATE1-2p can implement the Asp/Glu-
specific subset of the N-end rule pathway but differ in activity.
To determine whether the two putative mouse R-transferases
are in fact R-transferases and to compare their activities in an
in vivo setting, we examined whether ATE1-1p and ATE1-2p
could confer metabolic instability on Asp-bgal and Glu-bgal in
ate1D S. cerevisiae. Asp and Glu are secondary destabilizing
residues in the N-end rule (Fig. 1 and introduction). The test
substrates Asp-bgal and Glu-bgal (produced through cotrans-
lational deubiquitylation of Ub-Asp-bgal and Ub-Glu-bgal
(4)) are short-lived in wild-type yeast (half-lives of ;3 and ;30
min, respectively) but long-lived (half-life of .20 h) in ate1D S.
cerevisiae that lacks the ATE1-encoded yeast R-transferase (5,
7). Previous work (19, 33) has shown that the steady-state level
of an X-bgal protein is a sensitive measure of its metabolic
stability.
S. cerevisiae ate1D cells were cotransformed with a pair of
plasmids that expressed one of the two putative mouse R-
transferases, ATE1-1p or ATE1-2p, and one of several test
substrates (as the corresponding Ub fusions): Asp-bgal, Glu-
bgal, Arg-bgal, Cys-bgal, or Met-bgal. Met and Cys are stabi-
lizing residues in the yeast N-end rule; Arg is a primary desta-
bilizing residue; Asp and Glu are secondary destabilizing
residues (5, 56). Control tests included either the vector alone
or a plasmid expressing S. cerevisiae Ate1p. The steady-state
levels of X-bgal proteins were determined by measuring the
enzymatic activity of bgal in yeast extracts. Using this assay, we
found that both forms of mouse ATE1p were able to confer
metabolic instability on either Asp-bgal or Glu-bgal in ate1D S.
cerevisiae (Fig. 6A). ATE1-1p and ATE1-2p destabilized Glu-
bgal much less than Asp-bgal (Fig. 6A), consistent with Glu
being a less destabilizing residue in the N-end rule than Asp,
presumably because of less efficient arginylation of the N-
terminal Glu by R-transferases (54). However, while the ap-
parent destabilizing activity of the mouse ATE1-1p R-trans-
ferase was only slightly lower than that of S. cerevisiae Ate1p
(expressed from the identical vector and promoter), the activ-
ity of mouse ATE1-2p was significantly lower than that of
ATE1-1p (Fig. 6A).
We also asked whether the two forms of mouse ATE1p
could influence each other’s activity if they were coexpressed in
the same cell (such an influence might be expected, for in-
stance, if the active form of R-transferase were a dimer or if
the two forms of R-transferase competed for binding to the
same component of a pathway). S. cerevisiae ate1D cells were
cotransformed with two plasmids bearing different selectable
markers and expressing different combinations of ATE1-1p
and ATE1-2p (111, 212, or 112), and also with a plasmid
expressing one of the X-bgal test proteins (X 5 Met, Arg, Cys,
Asp, or Glu). Control cells were cotransformed with the two
FIG. 5. Alternative splicing of Ate1 pre-mRNA in mammals (the mouse) but in neither plants (A. thaliana) nor arthropods (D. melanogaster). (A) The relevant Ate1
cDNA fragments from mouse (794 bp). A. thaliana (626 bp), and D. melanogaster (856 bp) were produced by RT-PCR (see Materials and Methods). The products were
treated with the indicated restriction endonucleases that cut exclusively within the two alternative 129-bp exons of mouse Ate1 cDNAs (BspMI for Ate1-2; SexAI for
Ate1-1) or within the corresponding regions of A. thaliana (PvuII and ScrFI) and D. melanogaster (AccI and EcoRV) Ate1 cDNAs. (B) The A. thaliana and D.
melanogaster Ate1 genes. The exon-intron organization of these genes was deduced through comparisons of their cDNA sequences, determined in this work (see
Materials and Methods), with the concurrently determined sequences of the corresponding genomic DNA regions (see text). The horizontal lines and rectangles denote,
respectively, introns and exons, whose lengths are indicated below and above the line denoting introns. Thick horizontal lines indicate the regions of A. thaliana and
D. melanogaster cDNAs that correspond to the alternative 129-bp exons of the mouse and human Ate1 cDNAs (Fig. 2 and 4). The lengths of the A. thaliana and D.
melanogaster Ate1 genes are, respectively, ;3 and ;2.5 kb.
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vectors alone. The results (Fig. 6B) indicated that the total
activities of the 111 and 112 combinations (measured as the
extent of destabilization of Asp-bgal or Glu-bgal) were similar
to each other and much higher than the total activities of 212
(Fig. 6B), consistent with the conjecture that the two forms of
mouse R-transferase do not interact and that ATE1-1p is a
more (possibly much more) active enzyme than ATE1-2p.
Neither ATE1-1p nor ATE1-2p confers metabolic instability
on Cys-bgal. Cysteine is a stabilizing residue in the yeast N-end
rule but a secondary destabilizing residue in multicellular or-
ganisms such as mammals and amphibians (14, 18, 30, 54). The
presence of two alternative regions in the two forms of mouse
R-transferase (Fig. 4C) initially suggested that one R-trans-
ferase might be specific for N-terminal Asp and Glu, with the
other specific for Cys. However, Cys-bgal, which is long-lived
in wild-type S. cerevisiae (5), remained long-lived in the pres-
ence of either ATE1-1p or ATE1-2p (Fig. 6A). This finding
and, more directly, the results of amino acid sequencing (see
below) suggest the existence of a mammalian tRNA-depen-
dent enzyme (presumably a distinct R-transferase) (18) that
mediates destabilizing activity of N-terminal Cys.
Mouse ATE1-1p and ATE1-2p destabilize Asp-bgal and
Glu-bgal through arginylation of their N-terminal residues.
To verify directly that mouse ATE1-1p and ATE1-2p in fact
possess the R-transferase activity, we constructed the ate1D
ubr1D S. cerevisiae double mutant AVY34, which lacked both
R-transferase and N-recognin (E3), the main recognition com-
ponent of the N-end rule pathway (see Materials and Meth-
ods). Consequently, N-terminal arginylation of a test protein in
this mutant by an exogenous R-transferase would not result in
degradation of the protein, thereby making it possible to iso-
late enough of the test protein for N-terminal sequencing.
Strain AVY34 was transformed with pUB23-D (expressing
Ub-Asp-bgal) and also with either pAT1 (expressing ATE1-
1p), pAT2 (expressing ATE1-2p), or vector alone and was
grown in SG medium. Asp-bgal proteins isolated from these
transformants were subjected to N-terminal sequencing (see
Materials and Methods). The results (Table 1) directly con-
firmed that both ATE1-1p and ATE1-2p possessed R-trans-
ferase activity. In agreement with the finding that ATE1-1p
was more active than ATE1-2p in destabilizing Asp-bgal in
vivo (Fig. 6A), Asp-bgal from cells expressing ATE1-1p was
FIG. 6. The two forms of mouse ATE1p can implement the Asp/Glu-specific subset of the N-end rule pathway. (A) Relative enzymatic activities of bgal in ate1D
S. cerevisiae transformed with plasmids expressing X-bgal (as Ub-X-bgal) test proteins (X 5 Met, Arg, Cys, Asp, or Glu) together with a plasmid expressing either yeast
ATE1 (denoted as y), mouse ATE1-1p (denoted as 1), mouse ATE1-2p (denoted as 2), or the vector alone (denoted as v). The N-terminal residues of X-bgals in each
set of experiments are indicated at the top. The activity of Met-bgal in cells transformed with vector alone is taken as 100%. (B) The two forms of mouse ATE1p exhibit
no cooperativity in mediating the degradation of X-bgals. Shown are relative enzymatic activities of X-bgals in ate1D S. cerevisiae strain cotransformed with plasmids
expressing X-bgals (Ub-X-bgals) (X 5 Met, Arg, Cys, Asp, or Glu) and the combinations of plasmids expressing the following proteins: mouse ATE1-1p and ATE1-1p
(111), ATE1-1p and ATE1-2p (112), ATE1-2p and ATE1-2p (212), or two vector controls (v1v). One of the two vectors bore the TRP1 marker and the other bore
the HIS3 marker (see Materials and Methods). Results are averages of four independent measurements, which differed by less than 10%.
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found to be completely arginylated, whereas Asp-bgal from
cells expressing ATE1-2p was arginylated to approximately
50% (Table 1).
We also determined, using the above procedure, whether
mouse ATE1-1p or ATE1-2p could arginylate N-terminal Cys.
Approximately 80% of Cys-bgal isolated from ate1D ubr1D S.
cerevisiae was found to be N-terminally blocked, presumably
acetylated (Table 1). However, the rest of Cys-bgal (;20%)
bore the N-terminal sequence beginning with Cys and lacking
N-terminal Arg, in agreement with the results of the in vivo
Cys-bgal degradation assays (Fig. 6 and Table 1). Thus, both
ATE1-1p and Ate1-2p are apparently unable to utilize N-
terminal Cys as a substrate in S. cerevisiae.
ATE1-2p is exclusively cytosolic, whereas ATE1-1p is
present in either the nucleus or the cytosol. To determine the
intracellular location of the two forms of mouse R-transferase,
we constructed fusions to the N terminus of GFP and tran-
siently expressed them in NIH 3T3 cells. Whereas the free
26-kDa GFP was located in both the nucleus and the cytosol
(data not shown), the 85-kDa Ate1-2p–GFP fusion was exclu-
sively cytosolic in all of the many transfected cells examined
(Fig. 7a to c). In contrast, the 85-kDa ATE1-1p–GFP (the
alternative form of R-transferase that is much more active
enzymatically than ATE1-2p) was found to be localized differ-
ently in different cells on the same coverslip, possibly depend-
ing on their cell cycle position and/or metabolic state. Specif-
ically, in ;50% of the transfected cells, ATE1-1p–GFP was
exclusively cytosolic (Fig. 7d and e), as was ATE1-2p–GFP
(Fig. 7a to c), but in the other ;50% of cells, ATE1-1p–GFP
was present in the nucleus as well and, moreover, appeared to
be significantly enriched in the nucleus (Fig. 7f and g). Thus,
the two 43-residue alternative regions in ATE1-1p and
ATE1-2p confer overlapping but nonidentical intracellular dis-
tributions on the respective R-transferases.
While the nonuniformity of the ATE1-1p–GFP localization
among mouse cells in a single culture remains to be under-
stood, its preferential location in the nuclei of some cells is
consistent with a high content of basic residues in its 43-residue
region, in comparison to the alternative homologous region of
ATE1-2p (Fig. 2C). (No sequences fitting the consensus se-
quences of known nuclear localization signals could be de-
tected in the 43-residue region of ATE1-1p). In contrast to
mouse R-transferases, S. cerevisiae Ate1p was shown to be
located predominantly in the nuclei of yeast cells (56a).
The ratio of Ate1-1 to Ate1-2 mRNA varies greatly among
mouse tissues. Northern hybridization, using the 1.1-kb mouse
Ate1 cDNA fragment (nt 638 to 1734) as a probe, detected a
FIG. 7. Intracellular localization of mouse ATE1-1p and ATE1-2p. Shown are green (GFP) fluorescence (a to d and f) and phase-contrast (e and g) micrographs
of mouse NIH 3T3 cells transiently transfected with ATE1-1p-GFP (d to g) or ATE1-2p–GFP (a to c) fusion proteins (see Materials and Methods). Panels a to c show
different examples of the exclusively cytosolic localization of ATE1-2p. Regions around the nucleus and in the lamellar protrusions at the edges of a cell (c) exhibit
higher GFP fluorescence, possibly because of a greater thickness of cells in these areas. Panels d plus e and f plus g show pairs of GFP fluorescence and phase-contrast
pictures of cells that express ATE1-1p-GFP. The cell in panels d and e shows ATE1-1p-GFP in the cytosol but not in the nucleus. Cells in panels f and g contain
ATE1-1p-GFP in both the cytosol and the nucleus, the latter being apparently enriched in ATE1-lp-GFP.
TABLE 1. N-terminal sequencing of X-bgal proteins isolated from





D-eK-bgal Vector alone D-H-G-S-A- ;100
D-eK-bgal Mouse ATE1-1p R-D-H-G-S-A- ;100
D-eK-bgal Mouse ATE1-2p R-D-H-G-S-A- ;50
D-H-G-S-A- ;50
C-eK-bgal C-H-G-S-A-
C-eK-bgal Vector alone C-H-G-S-A- ;20
C-eK-bgal Mouse ATE1-1p C-H-G-S-A- ;20
C-eK-bgal Mouse ATE1-2p C-H-G-S-A- ;20
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single ;5.0-kb transcript (a mixture of the Ate1-1 and Ate1-2
mRNAs) in all of the mouse tissues examined except the testis,
where the ;5-kb Ate1 mRNA was a minor one, the major
species being ;2 kb (Fig. 8). Both ATE1p and the other
targeting components of the mammalian N-end rule pathway
are expressed ubiquitously (at various levels), and the testis-
specific patterns of transcripts are characteristic for all of them
as well (Fig. 8). The existence of the Y-chromosome-encoded,
testis-specific variant of the Ub-activating (E1) enzyme (27, 35)
suggests that the testis-specific modifications of the N-end rule
pathway may be functionally relevant in spermatogenesis.
To determine the ratio of Ate1-1 to Ate1-2 mRNA in differ-
ent mouse tissues or cells in culture, we employed RT-PCR,
using sequence differences between the two alternative, ho-
mologous 129-bp exons to distinguish between them (see Ma-
terials and Methods) (Fig. 3). Approximately equal amounts of
Ate1-1 and Ate1-2 mRNAs were present in mouse embryonic
fibroblasts and in human 293 cells in culture (Fig. 3 and data
not shown). However, the molar ratio of Ate1-1 to Ate1-2
mRNA was found to vary greatly among the mouse tissues: it
was ;0.1 in the skeletal muscle, ;0.25 in the spleen, ;3.3 in
the liver, and brain, and ;10 in the testis (Fig. 3). Thus, while
the total expression of Ate1 (Ate1-1 plus Ate1-2) varies by 2- to
4-fold among mouse tissues (Fig. 8), the difference in expres-
sion levels between Ate1-1 and Ate1-2 mRNAs can be as high
as a 100-fold (the skeletal muscle versus the testis) (Fig. 3),
suggesting that the two forms of R-transferase may be func-
tionally distinct.
DISCUSSION
The N-end rule pathway is one of several proteolytic path-
ways of the Ub system (23, 54, 55). Among the targets of the
N-end rule pathway are proteins that bear destabilizing N-
terminal residues. In the yeast S. cerevisiae, Asn and Gln are
tertiary destabilizing N-terminal residues in that they function
through their conversion, by a specific amidase (6), to the
secondary destabilizing N-terminal residues Asp and Glu. The
destabilizing activity of N-terminal Asp and Glu requires their
conjugation, by the ATE1-encoded R-transferase, to Arg, one
of the primary destabilizing residues (7) (Fig. 1B). In mam-
mals, the set of secondary destabilizing residues contains not
only Asp and Glu but also Cys, which is a stabilizing residue in
yeast (18, 54) (Fig. 1).
In this work, we isolated cDNA encoding the mouse R-
transferase, ATE1p, and found that this enzyme exists in two
forms, termed ATE1-1p and ATE1-2p, which differ by con-
taining one of the two alternative, homologous 43-residue re-
gions. The two 516-residue R-transferases are produced from
the mouse Ate1 gene by a pathway of alternative splicing that
retains one or the other of the two homologous 129-bp exons.
The presence of two adjacent, homologous, equal-length, and
alternatively utilized exons in a gene (Fig. 4) is nearly unprec-
edented. To our knowledge, just one such case was described
previously: the mouse kE2 enhancer-binding protein E12/E47
(37). The two kE2-binding proteins, E12 and E47, are pro-
duced through a switch between two alternative, equal-length
exons, resulting in two helix-loop-helix DNA-binding proteins
that differ in the ability to homodimerize. Specifically, E47 can
bind to the kE2 enhancer either as a homodimer or as a
heterodimer with MyoD, whereas E12 can bind as a het-
erodimer with MyoD but not as a homodimer (37).
We report the following major findings.
(i) Identification, through species walking, and isolation of
the mouse cDNA encoding R-transferase (or ATE1p) have
shown that mammalian ATE1p exists in two forms, ATE1-1p
and ATE1-2p, which differ exclusively by one of the two alter-
native, homologous 43-residue regions (Fig. 2A).
(ii) The corresponding alternative 129-bp exons are adjacent
in the mouse Ate1 gene. Moreover, the 12-bp sequences
around the splice acceptor sites of these exons (6 bp in the
intron and 6 bp in the exon) are identical between the two
exons (Fig. 4). The splicing of Ate1 pre-mRNA proceeds in
such way that one, and only one, of the alternative 129-bp
exons is always retained in the mature Ate1 mRNA.
(iii) The human ATE1 gene also contains the two alternative
129-bp exons, whereas the plant (A. thaliana) and fly (D. mela-
nogaster) Ate1 genes encode a single form of ATE1p (Fig. 2
and 5). The corresponding 43-residue regions are significantly
similar among all of the sequenced R-transferases, from S.
cerevisiae to mammals (Fig. 2C). The set of Ate1 genes from
mammals to yeast defines a distinct family of proteins, the
ATE family. The splicing-derived alternative forms of R-trans-
ferase have evolved apparently after the divergence of the
arthropod and vertebrate lineages.
(iv) Expression of the mouse Ate1-1 and Ate1-2 cDNAs in
ate1D S. cerevisiae, and N-terminal sequencing of isolated
X-bgal test proteins, was used to show that ATE1-1p and
ATE1-2p could implement the Asp/Glu-specific subset of the
N-end rule pathway and that they did so through the argin-
ylation of N-terminal Asp or Glu in the test substrates (Fig. 6A
and Table 1).
(v) While the destabilizing activity of the mouse ATE1-1p
R-transferase is only slightly lower than that of S. cerevisiae
R-transferase, the activity of mouse ATE1-2p is significantly
FIG. 8. Northern hybridization analyses of mouse Ate1 mRNA. The North-
ern blots of mRNA from different mouse tissues were probed with an Ate1 cDNA
fragment (nt 638 to 1734) which can hybridize to both forms of Ate1 mRNA. A
mouse b-actin cDNA probe was used for comparing the total RNA loads as
described previously (19). The same blot was also hybridized with mouse Ubr1
(29) (see the introduction). The apparent absence of Ate1 and Ubr1 mRNAs
from the spleen is an artifact of RNA degradation in this lane of the blot (data
not shown). Also shown are the results of analogous Northern hybridizations of
the mouse Ntan1 cDNA, encoding the Asn-specific Nt-amidase (Fig. 1A), and
E214K, encoding the relevant Ub-conjugating (E2) enzyme (19). The approxi-
mate sizes of transcripts are indicated on the right.
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(possibly considerably) lower than that of ATE1-1p. This con-
clusion follows also from a comparison of the N-terminal ar-
ginylation of Asp-bgal by the two R-transferases (Table 1).
The results of coexpressing mouse ATE1-1p and ATE1-2p in
the same ate1D yeast cells were consistent with the conjecture
that R-transferase functions as a monomer (Fig. 6B).
(vi) Neither ATE1-1p nor ATE1-2p could confer instability
on (or arginylate) Cys-bgal in ate1D S. cerevisiae (Fig. 6A and
Table 1). Cys is a stabilizing residue in yeast but a secondary
destabilizing residue in the mammalian N-end rule (54). A
distinct Cys-specific mammalian R-transferase suggested by
these data remains to be identified.
(vii) Mouse ATE1-2p (tested as a GFP fusion) was exclu-
sively cytosolic in mouse 3T3 cells, whereas ATE1-1p was lo-
calized differentially in different cells of the same (unsynchro-
nized) culture: it was either exclusively cytosolic or present in
both the cytosol and the nucleus (Fig. 7).
(viii) Mouse Ate1 is a ubiquitously expressed gene. A single
;5-kb mRNA was present in all of the tissues examined except
the testis, where the major Ate1 transcript was ;2 kb in length
(Fig. 8). The testis-specific differential expression patterns are
also characteristic of the other targeting components of the
mammalian N-end rule pathway, such as the Ntan1-encoded
Asn-specific Nt-amidase and the Ubr1-encoded N-recognin
(E3a) (19, 29).
(ix) The molar ratio of Ate1-1 to Ate1-2 mRNA varies up to
a 100-fold among different mouse tissues (Fig. 3 and Results),
suggesting a functional significance of the difference between
the two R-transferases.
The region of ATE1p that corresponds to the two 129-bp
mammalian Ate1 exons has been significantly conserved
throughout eukaryotic evolution, Tyr-296, Gln-297, and His-
301 of the mouse ATE1-1p being among the most highly con-
served residues (Fig. 2C). No putative members of the ATE
family could be detected among the currently known prokary-
otic ORFs. The most highly conserved region of R-transferases
is an 82-residue stretch (residues 336 to 417) of mouse ATE1p:
this region is 95, 76, and 63% identical to the corresponding
regions of the human, D. melanogaster, and A. thaliana ATE1p,
respectively (Fig. 2B). A Cys residue(s) is likely to be a com-
ponent of the active site of R-transferase (31, 32). Among the
five fully conserved Cys residues in proteins of the ATE family,
four are located in the 56-residue N-terminal region (residues
23 to 78 of mouse ATE1p) (Fig. 2B). Conversion of some of
these cysteines in S. cerevisiae Ate1p to alanines was found to
decrease greatly the R-transferase activity of yeast Ate1p (16a,
32). Furthermore, derivatives of mouse ATE1-1p and ATE1-2p
that lacked the first 42 residues were completely inactive in the
yeast-based Asp-bgal degradation assay of a kind described in
Fig. 7 (data not shown). Finally, a 90-residue C-terminal trun-
cation of S. cerevisiae Ate1p did not result in a major decrease
of its R-transferase activity (16a). Thus, the active site of R-
transferase is likely to encompass at least some of the above
N-terminal cysteines.
Since the two mammalian R-transferases (Fig. 4C) are iden-
tical in size and, except for a 43-residue region, are identical
otherwise as well, it is likely that the previously described
(partially purified) mammalian R-transferases (12, 47) were in
fact mixtures of Ate1-1p and Ate1-2p. On the other hand,
fractionation of a crude R-transferase preparation from rabbit
reticulocytes did yield, in addition to a major fraction of R-
transferase, chromatographically distinct R-transferase frac-
tions that were not investigated further (12). The ratio of
Ate1-1p to Ate1-2p in rabbit reticulocytes is currently un-
known.
A splicing-mediated switch that replaces the 129-bp Ate1
exon of ATE1-1p with the alternative 129-bp exon results in a
protein, ATE1-2p, that has a significantly (possibly consider-
ably) lower R-transferase activity (Fig. 6). In addition,
ATE1-2p is unable to enter the nucleus (as a GFP fusion), in
contrast to ATE1-1p (Fig. 7). Taken together with the finding
that the expression ratio of the two Ate1 mRNAs, Ate1-1 and
Ate1-2, varies up to a 100-fold among different mouse tissues
(Fig. 3 and Results), these data suggest that the two R-trans-
ferases are functionally distinct as well. Cited below are some
of the possibilities that are consistent with the available evi-
dence.
Mouse ATE1-2p has the R-transferase activity but arginyl-
ates, at steady state, only ;50% of Asp-bgal in ate1D S. cer-
evisiae, in contrast to both ATE1-2p and S. cerevisiae Ate1p
(Fig. 6 and Table 1). Moreover, the inefficient arginylation by
ATE1-2p occurs in spite of its overexpression in S. cerevisiae.
In contrast, the yeast Ate1p, which in wild-type S. cerevisiae is
a weakly expressed protein (7), can quantitatively arginylate in
vivo an overexpressed substrate such as Asp-bgal (18). Thus, at
a low level of expression (which is likely to be the case in the
mouse), the ATE1-2p R-transferase may be, in effect, an in-
active enzyme, in contrast to ATE1-1p. If so, ATE1-2p might
act as an (indirect) inhibitor of the ATE1-1p function, for
example, through a competition with ATE1-1p for the binding
to a component of the targeting complex in the N-end rule
pathway. (The apparent absence of such competition in S.
cerevisiae [Fig. 6B] may result from the lack of binding by
ATE1p to heterologous yeast proteins.) It is also possible that
a large difference in activity between mouse ATE1-1p and
ATE1-2p in yeast reflects not their different enzymatic activi-
ties in the mouse but a (physiologically irrelevant) differential
recognition of an essential yeast cofactor such as Arg-tRNA.
Direct comparisons of arginylation kinetics by the purified
mouse and yeast R-transferases will be required to address this
unlikely but unexcluded interpretation.
Another possibility is that ATE1-2p has a distinct enzymatic
activity that has been missed by the current N-terminal ar-
ginylation assay (Fig. 6 and Table 1). For example, ATE1-2p
might be able to arginylate an internal residue in a substrate
protein. In vitro enzymological dissection of ATE1-1p and
ATE1-2p will address this and related conjectures. Yet an-
other possibility is that the alternative 43-residue regions of
ATE1-1p and ATE1-2p confer different metabolic stabilities
on the two R-transferases, the lower apparent activity of
ATE1-2p in yeast being due at least in part to its shorter
half-life. A test of this model in mouse cells requires antibodies
specific for the alternative regions of the two R-transferases;
preparation of such antibodies is under way.
In yeast, the N-end rule pathway is present in both the
cytosol and the nucleus. The apparent exclusion of mouse
ATE1-2p from the nucleus and the different ratios of Ate1-1 to
Ate1-2 mRNA among the mouse tissues suggest that the rule
book of the N-end rule pathway may be regulated differentially
in the cytosol and the nucleus, through a cell-type-specific
expression of the pathway’s components that are located in one
but not the other compartment.
Physiological substrates for either eukaryotic R-transferases
(54) or their prokaryotic counterparts, L, F-transferases (1, 25,
45) are not known. The cloning and characterization of the first
mammalian Ate1 cDNAs and genes (Fig. 2), and the discov-
ery of alternative splicing that yields mouse ATE1-1p and
ATE1-2p (Fig. 4) should facilitate understanding of the func-
tions of mammalian R-transferases, in part through the anal-
ysis of ATE1-1p and ATE1-2p enzymes and also because it is
now possible to construct mouse strains that lack ATE1-1p
and/or ATE1-2p.
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